Editorial: Epigenetic therapy against cancer: toward new molecular targets and technologies

• Ângela Sousa,
• Christiane P. Soares,
• Chung Man Chin,
• Chung Man Chin,
• Daniela Trisciuoglio,
• Fatima Valdes-Mora,
• Fatima Valdes-Mora

Affiliations

Ângela Sousa

CICS-UBI—Health Science Research Centre, University of Beira Interior, Covilhã, Portugal

Christiane P. Soares

School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil

Chung Man Chin

School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara, Brazil

Chung Man Chin

School of Medicine, UNION of the Colleges of the GREAT LAKES (UNILAGO), Sao José do Rio Preto, Brazil

Daniela Trisciuoglio

IBPM Institute of Molecular Biology and Pathology, CNR National Research Council, C/o Department of Biology and Biotechnology “Charles Darwin”, Sapienza University of Rome, Rome, Italy

Fatima Valdes-Mora

Children’s Cancer Institute Australia Randwick, Randwick, NSW, Australia

Fatima Valdes-Mora

Garvan Institute of Medical Research Darlinghurst, Darlinghurst, NSW, Australia